Novartis Investigative Site

Pau 64046

0 studies enrolling now · 2 studies all time

What they study most

Atherosclerotic Cardiovascular Disease, Heart Failure With Reduced Ejection Fraction (HF-rEF)

Studies at this site

• Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease — Running, not enrolling
• Multiple Patient Program to Ensure Access to LCZ696 Treatment to Patients Diagnosed With Heart Failure With Reduced Ejection Fraction (HF-rEF) — NO_LONGER_AVAILABLE